⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ORIC News
Oric Pharmaceuticals, Inc. Common Stock
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ORIC
Form 8-K
sec.gov
ORIC
Form 8-K
sec.gov
ORIC
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates
globenewswire.com
ORIC
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ORIC
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
globenewswire.com
ORIC
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
prnewswire.com
ONCY
NRIX
ERAS
FHTX
ORIC
ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones
globenewswire.com
ORIC
ORIC® Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
ORIC
ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025
globenewswire.com
ORIC